Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States

PURPOSE: Oral targeted therapies represent a significant advance for the treatment of patients with chronic lymphocytic leukemia (CLL); however, their high cost has raised concerns about affordability and the economic impact on society. Our objective was to project the future prevalence and cost bur...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Chen, Qiushi, Jain, Nitin, Ayer, Turgay, Wierda, William G., Flowers, Christopher R., O’Brien, Susan M., Keating, Michael J., Kantarjian, Hagop M., Chhatwal, Jagpreet
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2017
Subjects:
ORIGINAL REPORTS
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5559889/
https://ncbi.nlm.nih.gov/pubmed/27870563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.68.2856
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items